| 000 | 00999 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250518054811.0 | ||
| 264 | 0 | _c20200626 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1365-2133 | ||
| 024 | 7 |
_a10.1111/bjd.18450 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWaldman, R A | |
| 245 | 0 | 0 |
_aDoes interleukin-4 inhibition play a role in dupilumab-associated conjunctivitis? _h[electronic resource] |
| 260 |
_bThe British journal of dermatology _c01 2020 |
||
| 300 |
_a251 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 | _aConjunctivitis |
| 650 | 0 | 4 | _aDermatitis, Atopic |
| 650 | 0 | 4 | _aGoblet Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInflammation |
| 650 | 0 | 4 | _aInterleukin-4 |
| 700 | 1 | _aDeWane, M E | |
| 700 | 1 | _aSloan, S B | |
| 773 | 0 |
_tThe British journal of dermatology _gvol. 182 _gno. 1 _gp. 251 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bjd.18450 _zAvailable from publisher's website |
| 999 |
_c30029611 _d30029611 |
||